Self-reproducing protein aggregates of a fibrillar nature (amyloids) are associated with a number of animal and human diseases. Some amyloids (prions) possess infectious properties as they can be transmitted between tissues, organs, and even organisms. However, there are examples of prions and amyloids that have normal biological functions [1]. The number of proteins capable of forming functional and pathological amyloids is constantly expanding. For example, some bioinformatics algorithms predict that over a hundred human proteins may have the ability to form amyloids.
In our study, we applied the ArchCandy algorithm to identify human proteins with amyloidogenic properties. This algorithm is capable of identifying the potential formation of β-arches (structures specific to amyloid proteins). By applying an in silico approach, we selected nine proteins that demonstrated amyloidogenic potential and experimentally validated these predictions. To evaluate the amyloidogenic potential of proteins, we employed an original yeast test system that we developed [2]. This system enables us to assess amyloidogenicity of individual proteins as well as to conduct large-scale screenings of amyloidogenic proteins using a genetic analysis. Using this test system, we demonstrated that six out of the nine predicted amyloidogenic proteins were prone to amyloid formation. Among the proteins that demonstrated amyloidogenic properties, there were proteins involved in chromatin remodeling, transcription regulation, and oncogenesis. For several potentially amyloidogenic proteins identified in the yeast model, their amyloid properties were confirmed both in vitro and in a human cell culture.
Author Contributions
Conceptualization, Y.O.C. and A.A.R.; data acquisition and formal analysis, A.A.Z. and M.V.R.; supervision, A.A.R., funding acquisition, A.A.R., writing—review and editing, A.A.Z. and A.A.R. All authors have read and agreed to the published version of the manuscript.
Funding
This research was supported by St. Petersburg State University (project No. 95444727).
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
Not applicable.
Conflicts of Interest
The authors declare no conflict of interest.
References
- Rubel, M.S.; Fedotov, S.A.; Grizel, A.V.; Sopova, J.V.; Malikova, O.A.; Chernoff, Y.O.; Rubel, A.A. Functional Mammalian Amyloids and Amyloid-Like Proteins. Life 2020, 10, 156. [Google Scholar] [CrossRef] [PubMed]
- Chandramowlishwaran, P.; Sun, M.; Casey, K.L.; Romanyuk, A.V.; Grizel, A.V.; Sopova, J.V.; Rubel, A.A.; Nussbaum-Krammer, C.; Vorberg, I.M.; Chernoff, Y.O. Mammalian amyloidogenic proteins promote prion nucleation in yeast. J. Biol. Chem. 2018, 293, 3436–3450. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).